IGF1R and breast cancer: (2000) also showed that insulin receptor substrate‐1 (IRS‐1) and IGF1R are expressed at high levels in control tissues and in well and moderately differentiated carcinomas, but at significantly lower levels in poorly differentiated breast cancers.